243 related articles for article (PubMed ID: 21584493)
1. Differentially expressed microRNAs and their target genes in the hearts of streptozotocin-induced diabetic mice.
Diao X; Shen E; Wang X; Hu B
Mol Med Rep; 2011; 4(4):633-40. PubMed ID: 21584493
[TBL] [Abstract][Full Text] [Related]
2. Relationship between downregulation of miRNAs and increase of oxidative stress in the development of diabetic cardiac dysfunction: junctin as a target protein of miR-1.
Yildirim SS; Akman D; Catalucci D; Turan B
Cell Biochem Biophys; 2013; 67(3):1397-408. PubMed ID: 23723006
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord-derived mesenchymal stromal cells improve myocardial fibrosis and restore miRNA-133a expression in diabetic cardiomyopathy.
Liu B; Wei Y; He J; Feng B; Chen Y; Guo R; Griffin MD; Hynes SO; Shen S; Liu Y; Cui H; Ma J; O'Brien T
Stem Cell Res Ther; 2024 Apr; 15(1):120. PubMed ID: 38659015
[TBL] [Abstract][Full Text] [Related]
4. miR133a regulates cardiomyocyte hypertrophy in diabetes.
Feng B; Chen S; George B; Feng Q; Chakrabarti S
Diabetes Metab Res Rev; 2010 Jan; 26(1):40-9. PubMed ID: 20013939
[TBL] [Abstract][Full Text] [Related]
5. Curcumin prevents diabetic cardiomyopathy in streptozotocin-induced diabetic rats: possible involvement of PKC-MAPK signaling pathway.
Soetikno V; Sari FR; Sukumaran V; Lakshmanan AP; Mito S; Harima M; Thandavarayan RA; Suzuki K; Nagata M; Takagi R; Watanabe K
Eur J Pharm Sci; 2012 Oct; 47(3):604-14. PubMed ID: 22564708
[TBL] [Abstract][Full Text] [Related]
6. Different gene expression in human heart tissue and progenitor cells from control and diabetic subjects: relevance to the pathogenesis of human diabetic cardiomyopathy.
de Cillis E; Leonardini A; Laviola L; Giorgino F; Tupputi Schinosa Lde L; Bortone AS
Surg Technol Int; 2010 Apr; 19():165-74. PubMed ID: 20437361
[TBL] [Abstract][Full Text] [Related]
7. Role of CCR2 in the Development of Streptozotocin-Treated Diabetic Cardiomyopathy.
Tan X; Hu L; Shu Z; Chen L; Li X; Du M; Sun D; Mao X; Deng S; Huang K; Zhang F
Diabetes; 2019 Nov; 68(11):2063-2073. PubMed ID: 31439648
[TBL] [Abstract][Full Text] [Related]
8. miR-200b Mediates Endothelial-to-Mesenchymal Transition in Diabetic Cardiomyopathy.
Feng B; Cao Y; Chen S; Chu X; Chu Y; Chakrabarti S
Diabetes; 2016 Mar; 65(3):768-79. PubMed ID: 26718496
[TBL] [Abstract][Full Text] [Related]
9. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice.
Ueno M; Suzuki J; Zenimaru Y; Takahashi S; Koizumi T; Noriki S; Yamaguchi O; Otsu K; Shen WJ; Kraemer FB; Miyamori I
Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1109-18. PubMed ID: 18413675
[TBL] [Abstract][Full Text] [Related]
10. Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice.
Zheng D; Ma J; Yu Y; Li M; Ni R; Wang G; Chen R; Li J; Fan GC; Lacefield JC; Peng T
Diabetologia; 2015 Aug; 58(8):1949-58. PubMed ID: 25994075
[TBL] [Abstract][Full Text] [Related]
11. [Investigation on the differentially expressed circular RNAs in myocardium of mice with diabetic cardiomyopathy].
Wu XG; Zhang SC; Zhou X
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 May; 50(5):501-508. PubMed ID: 35589600
[No Abstract] [Full Text] [Related]
12. Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice.
Wang Y; Ebermann L; Sterner-Kock A; Wika S; Schultheiss HP; Dörner A; Walther T
Exp Physiol; 2009 Feb; 94(2):220-7. PubMed ID: 18945756
[TBL] [Abstract][Full Text] [Related]
13. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1.
Marfella R; D'Amico M; Di Filippo C; Piegari E; Nappo F; Esposito K; Berrino L; Rossi F; Giugliano D
Diabetologia; 2002 Aug; 45(8):1172-81. PubMed ID: 12189448
[TBL] [Abstract][Full Text] [Related]
14. Altered retinal microRNA expression profiles in early diabetic retinopathy: an in silico analysis.
Xiong F; Du X; Hu J; Li T; Du S; Wu Q
Curr Eye Res; 2014 Jul; 39(7):720-9. PubMed ID: 24502381
[TBL] [Abstract][Full Text] [Related]
15. Nuclear miR-320 Mediates Diabetes-Induced Cardiac Dysfunction by Activating Transcription of Fatty Acid Metabolic Genes to Cause Lipotoxicity in the Heart.
Li H; Fan J; Zhao Y; Zhang X; Dai B; Zhan J; Yin Z; Nie X; Fu XD; Chen C; Wang DW
Circ Res; 2019 Dec; 125(12):1106-1120. PubMed ID: 31638474
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles and bioinformatic analysis of microRNAs in myocardium of diabetic cardiomyopathy mice.
Wang T; Yuan L; Chen Y; Wang J; Li N; Zhou H
Genes Genomics; 2023 Aug; 45(8):1003-1011. PubMed ID: 37253907
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA profiling unveils hyperglycaemic memory in the diabetic heart.
Costantino S; Paneni F; Lüscher TF; Cosentino F
Eur Heart J; 2016 Feb; 37(6):572-6. PubMed ID: 26553540
[TBL] [Abstract][Full Text] [Related]
18. FT23, an orally active antifibrotic compound, attenuates structural and functional abnormalities in an experimental model of diabetic cardiomyopathy.
Tan SM; Zhang Y; Wang B; Tan CY; Zammit SC; Williams SJ; Krum H; Kelly DJ
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):650-6. PubMed ID: 22612418
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Gsalpha compensates for myocyte loss in diabetic cardiomyopathy.
Malhotra A; Kang BP; Vashistha H; Yadav VS; Meggs LG
Can J Physiol Pharmacol; 2008 Mar; 86(3):122-30. PubMed ID: 18418439
[TBL] [Abstract][Full Text] [Related]
20. The effect of a preparation of minerals, vitamins and trace elements on the cardiac gene expression pattern in male diabetic rats.
Sárközy M; Szűcs G; Pipicz M; Zvara Á; Éder K; Fekete V; Szűcs C; Bárkányi J; Csonka C; Puskás LG; Kónya C; Ferdinandy P; Csont T
Cardiovasc Diabetol; 2015 Jun; 14():85. PubMed ID: 26126619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
